Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahyd rofuran-2-yl)-9H-purin-2-yl]-prop-2-ynyl} - piperidine-1-carboxylic acid esters as A2AR agonists
Details for Australian Patent Application No. 2008340186 (hide)
International Classifications
Event Publications
22 July 2010 PCT application entered the National Phase
PCT publication WO2009/082720 Priority application(s): WO2009/082720
29 July 2010 Corrigenda
PCT applications that have entered the National Phase - Name Index Under name PGx Health, LLC, Application No. 2008340186, under INID (71) corrected the applicant name to PGxHealth, LLC
24 March 2011 Alteration of Name
The name of the applicant has been altered to Trovis Pharmaceuticals LLC
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
2008340192-Method and apparatus for monitoring voltage in a meter network
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
- Editable Word format reports
- For IP Professionals
- Multiuser